NCT00003605View on ClinicalTrials.gov

Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 1998

Primary Completion Date

January 31, 2000

Study Completion Date

January 31, 2000

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

cyclophosphamide

Trial Locations (3)

47402

Bloomington Hospital, Bloomington

77802

St. Joseph Regional Cancer Center, Bryan

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors
All Listed Sponsors
collaborator

Cancer Biotherapy Research Group

OTHER

lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00003605 - Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter